Because of this, it also seems reasonable to come to know the molecular foundation that lies at the basis of overweight/ obesity, in which a key factor in maintaining the balance between energy and appetite is leptin [1,2], therefore cisplatin may influence the loss of body mass through affecting the expression of leptin during anticancer therapy. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.